Drug intelligence / Profile preview

codeine + triprolidine

Development stage
Unknown
Lead developer
Ravian Pharmaceuticals
Modality
Small Molecules
Administration
Oral
01

Overview

Prodyl C is a combination pharmaceutical product formulated as an oral syrup, containing the opioid antitussive codeine and the first-generation antihistamine triprolidine. Developed and marketed by Ravian Pharmaceuticals, it is indicated for the symptomatic relief of cough and upper respiratory symptoms associated with the common cold or allergic rhinitis. Codeine functions as a central cough suppressant by acting as an agonist at mu-opioid receptors in the medullary cough center, thereby increasing the cough threshold. Triprolidine provides relief from sneezing, rhinorrhea, and itchy eyes by competitively antagonizing histamine H1 receptors. As a commercial generic formulation, Prodyl C is used for the management of non-productive cough and associated allergic symptoms in pediatric and adult populations where approved.

Brand names
Prodyl C
Other names
PRODYL C Syrup
02

Targets

HRH1 (Histamine H1 Receptor)MOR (Mu opioid receptor)

Beyond the preview

Go deeper on codeine + triprolidine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on codeine + triprolidine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call